Ventyx Biosciences Inc (VTYX)

Dec 19, 2024

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Insider John Nuss Sells 13,161 Shares - MarketBeat

Dec 19, 2024

Dec 19, 2024

Ventyx Biosciences' chief scientific officer sells $29,682 in stock - Investing.com

Dec 19, 2024

Dec 19, 2024

Ventyx Biosciences' chief scientific officer sells $29,682 in stock By Investing.com - Investing.com UK

Dec 19, 2024

Dec 19, 2024

Insiders Enjoy US$190k Return After Buying Ventyx Biosciences Stock - Simply Wall St

Dec 19, 2024

Dec 17, 2024

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Dec 17, 2024

Dec 17, 2024

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 17, 2024

Dec 14, 2024

Ventyx Biosciences Insiders Land Bargain With Gains Of US$180k - Yahoo Finance

Dec 14, 2024

Dec 10, 2024

VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Dec 10, 2024

Dec 10, 2024

Cryopyrin-associated Periodic Syndromes Market on Track for Major Expansion by 2034, According to DelveInsight | Amgen, Biovitrum, Novartis, Ventyx Biosciences - The Globe and Mail

Dec 10, 2024

Dec 05, 2024

Neurogene and Ventyx Biosciences rises after insider buying by executives - MSN

Dec 05, 2024

Nov 29, 2024

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Bought by Vestal Point Capital LP - MarketBeat

Nov 29, 2024

Nov 29, 2024

Sio Capital Management LLC Raises Stock Holdings in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - MarketBeat

Nov 29, 2024

Nov 26, 2024

Hedge Fund and Insider Trading News: Bill Ackman, Paul Tudor Jones, Whitney Tilson, Steven Cohen, Scott Bessent, Millennium Management, Paloma Partners, Ventyx Biosciences Inc (VTYX), Vistra Corp (VST), and More - Insider Monkey

Nov 26, 2024

Nov 26, 2024

Ventyx Biosciences Inc (NASDAQ: VTYX) Jumps 11.35%, Turning Investors Away - Stocks Register

Nov 26, 2024

Nov 26, 2024

Ventyx Biosciences CEO Mohan Raju buys $959,889 in stock By Investing.com - Investing.com Australia

Nov 26, 2024

Nov 25, 2024

Ventyx Biosciences CEO Mohan Raju buys $959,889 in stock - Investing.com

Nov 25, 2024

Nov 22, 2024

Analysts Set Ventyx Biosciences, Inc. (NASDAQ:VTYX) Price Target at $10.00 - MarketBeat

Nov 22, 2024

Nov 20, 2024

Thinking about buying stock in Solid Power, Crowdstrike Holdings - GuruFocus.com

Nov 20, 2024

Nov 19, 2024

Ventyx Biosciences stock hits 52-week low at $1.78 amid market shifts - Investing.com Australia

Nov 19, 2024

Nov 17, 2024

Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) latest 15% decline adds to one-year losses, institutional investors may consider drastic measures - Yahoo Finance

Nov 17, 2024

Nov 14, 2024

We Think Ventyx Biosciences (NASDAQ:VTYX) Needs To Drive Business Growth Carefully - Simply Wall St

Nov 14, 2024

Nov 12, 2024

Ventyx Biosciences Reports Q3 Financial Results and Pipeline Progress - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences - The Manila Times

Nov 12, 2024

Nov 11, 2024

Ventyx Biosciences (NASDAQ:VTYX) Earns "Neutral" Rating from HC Wainwright - MarketBeat

Nov 11, 2024

Nov 11, 2024

Ventyx Biosciences’ (VTYX) “Outperform” Rating Reiterated at Oppenheimer - Defense World

Nov 11, 2024

Nov 08, 2024

Ventyx Biosciences (NASDAQ:VTYX) Given "Outperform" Rating at Oppenheimer - MarketBeat

Nov 08, 2024

Nov 07, 2024

Ventyx Biosciences Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Progress - The Manila Times

Nov 07, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Ventyx Biosciences Inc - GuruFocus.com

Nov 05, 2024

Nov 04, 2024

Ventyx Biosciences: Ready To Escape "The Crash Cycle" (NASDAQ:VTYX) - Seeking Alpha

Nov 04, 2024

Nov 01, 2024

Thinking about buying stock in QuickLogic, Ventyx Biosciences, D - GuruFocus.com

Nov 01, 2024

Oct 28, 2024

These 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts - Markets Insider

Oct 28, 2024

Oct 28, 2024

Brokerages Set Ventyx Biosciences, Inc. (NASDAQ:VTYX) PT at $8.29 - MarketBeat

Oct 28, 2024

Oct 17, 2024

HC Wainwright Cuts Earnings Estimates for Ventyx Biosciences - MarketBeat

Oct 17, 2024

Oct 16, 2024

Ventyx Biosciences maintains Neutral rating from H.C. Wainwright - Investing.com

Oct 16, 2024

Oct 16, 2024

Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 in Ulcerative Colitis at UEG Week 2024 - Marketscreener.com

Oct 16, 2024

Oct 16, 2024

Ventyx Biosciences maintains Neutral rating from H.C. Wainwright By Investing.com - Investing.com UK

Oct 16, 2024

Oct 16, 2024

Ventyx Biosciences Presents New 52-Week Results from the - GlobeNewswire

Oct 16, 2024

Oct 15, 2024

Ventyx Biosciences (NASDAQ:VTYX) Given "Neutral" Rating at HC Wainwright - MarketBeat

Oct 15, 2024

Oct 15, 2024

Ventyx reports positive Phase 2 ulcerative colitis trial data - Investing.com

Oct 15, 2024

Oct 15, 2024

Ventyx reports positive Phase 2 ulcerative colitis trial data By Investing.com - Investing.com Canada

Oct 15, 2024

Oct 15, 2024

VTYX’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Oct 15, 2024

Oct 15, 2024

Ventyx Biosciences Inc (VTYX) stock analysis: A comprehensive overview - US Post News

Oct 15, 2024

Oct 15, 2024

Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024 - The Manila Times

Oct 15, 2024

Oct 08, 2024

Did Ventyx Biosciences Inc (VTYX) perform well in the last session? - US Post News

Oct 08, 2024